Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NAD questions Nutrition 21 ads

This article was originally published in The Tan Sheet

Executive Summary

Absolute claims that the company's Core4Life Advanced Memory Formula "increases alertness and concentration" and "helps improve focus and vitality" are unsupported and should be modified or discontinued, the National Advertising Division of the Council of Better Business Bureaus advises in a Nov. 25 decision. Purchase, N.Y.-based Nutrition 21 sufficiently backs other ingredient-specific claims, NAD finds. The nutritional bioscience firm says the ingredient research supports its broader product claims, but agrees to consider NAD's conclusions in developing future Core4Life ads. The formula, introduced in November 2007, is marketed to baby boomers as an aid to more efficiently process glucose, the brain's "fuel" (1"The Tan Sheet" Nov. 26, 2007, p. 5)

You may also be interested in...



New Products In Brief

Omega-3/vitamin K supplement: The first supplement in North America to combine omega-3 and vitamin K will launch under a partnership between Ocean Nutrition Canada, which markets the MEG-3 brand Omega-3 EPA/DHA products and PL Thomas, a New Jersey supplier of MenaQ7 Natural Vitamin K2, firms announce Nov. 5. "The many health benefits of EPA and DHA from fish oil are well recognized, and with this new offering, consumers specifically interested in cardiovascular health benefits will also receive natural vitamin K2 as MK-7, which is shown to further promote vascular health," ONC says. ONC said several of its customers are developing products combining Meg-3 and MenaQ7 in formulations targeting heart health...

At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use

At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.

Simplified Clinical Trial Transparency Rules To Go Live In The EU In June

A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules. 

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102359

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel